Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors

OBJECTIVES: To assess the efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis (RA) and poor prognostic factors. METHODS: In this double-blind, phase IIIb study, patients with RA for 2 years or less were randomly assigned 1 : 1 to receive abatacept (∼10 mg/...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhovens, R, Robles, M, Ximenes, A C, Nayiager, S, Wollenhaupt, J, Durez, P, Gomez-Reino, J, Grassi, W, Haraoui, B, Shergy, W, Park, S-H, Genant, H, Peterfy, C, Becker, J-C, Covucci, A, Helfrick, R, Bathon, J
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770104/
https://www.ncbi.nlm.nih.gov/pubmed/19124524
http://dx.doi.org/10.1136/ard.2008.101121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770104/
https://www.ncbi.nlm.nih.gov/pubmed/19124524
http://dx.doi.org/10.1136/ard.2008.101121

Ejemplares similares